Nightstar Therapeutics Plc (NITE) Annual Balance Sheets

Annual · GAAP · USD millions
Access NITE quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Nightstar Therapeutics Plc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2018)
(Dec 31 2017)
Assets
Cash & cash equivalent27.78
Marketable Securities, Current SH136.39
Cash & Short-term Investments163.00
Notes Receivable, Current0.13
Other Current Assets8.27
Prepaid Expense And Other Assets Current6.61
Total Current Assets179.04
Equipment/Property/Plant Net0.56
Tax Assets, Noncurrent9.48
Other Assets, Noncurrent0.41
Total Assets180.01
Liabilities
Accounts Payable, Current AC3.02
Accrued Liabilities, Current2.42
Other Liabilities, Current0.00
Total Current Liabilities14.38
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.43
Accrued Liabilities And Other Liabilities Current11.36
Total Liabilities14.38
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock267.23
Retained Earnings / Accumulated Deficit-98.88
Accumulated Other Comprehensive Income2.08
Other Equity-2.77
Common Stockholder's Equity165.64
Total Stockholder's Equity165.64
Liabilities & Stockholder's Equity180.01
4 historic quarters locked

Sign in to unlock the full Nightstar Therapeutics Plc balance sheet history.

About NITE Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License